During the past decade, Great Lakes Clinical Trials - Andersonville conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Great Lakes Clinical Trials - Andersonville" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (1 trials) and "Influenza, Human" (1 trials). Many other conditions were trialed in "Great Lakes Clinical Trials - Andersonville" in a lesser frequency.

Most popular intervention types in "Great Lakes Clinical Trials - Andersonville" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Donanemab" (2 trials), "PF-07836391 Influenza saRNA" (1 trials), "PF-07836394 Influenza saRNA" (1 trials) and "PF-07836395 Influenza saRNA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Great Lakes Clinical Trials - Andersonville" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Great Lakes Clinical Trials - Andersonville". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Great Lakes Clinical Trials - Andersonville, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Great Lakes Clinical Trials - Andersonville, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".